Open Access
29-01-2025 | Heart Failure | Mini Review
Renal denervation in the setting of heart failure
Authors:
Franziska Koppe-Schmeißer, Karl Fengler, Karl-Patrik Kresoja, Philipp Lurz, Karl-Philipp Rommel
Published in:
Heart Failure Reviews
Login to get access
Abstract
Renal Denervation (RDN) has emerged over the last decade as a third pillar in the treatment of arterial hypertension, alongside pharmacotherapy and lifestyle modifications. Mechanistically, it reduces central sympathetic overactivation, a process also relevant to heart failure. In this mini-review, we summarize the development of RDN for heart failure, discuss the current evidence supporting its effects, and provide an outlook on future developments.